Market Research Logo

Global Splenomegaly Therapeutics Market 2019-2023

Global Splenomegaly Therapeutics Market 2019-2023

About this market

The availability of clinical practice guidelines improves the quality of life of patients, as well as the consistency of care. There are several guidelines and care pathways for the management of splenomegaly, which have been developed by hospitals and professional societies. These are published and practiced with the aim of standardizing disease management in patients with splenomegaly. For instance, the Hospital for Sick Children has developed a clinical practice guideline for clinicians to provide adequate disease management in children with splenomegaly. In developing countries such as India, the Association of Physicians of India published guidelines for a clinical approach for appropriate diagnosis and management of splenomegaly. Technavio’s analysts have predicted that the splenomegaly therapeutics market will register a CAGR of almost 3% by 2023.

Market Overview

Rising awareness of splenomegaly

The incidence of splenomegaly has been seen along with many primary indications, including infections, autoimmune disorders, and hematological malignancies, which are increasing globally. Hence, the governments of various countries and several non-governmental organizations are striving to increase patient awareness about splenomegaly.

Challenges associated with diagnosis of splenomegaly

Splenomegaly is a nonspecific finding, which is challenging to assess diagnostically, as it is generally a manifestation of an underlying primary disorder. The highly advanced procedures such as point-of-care ultrasonography for the diagnosis for splenomegaly have high sensitivity compared with conventional imaging techniques. However, the poor patient access because of the high cost limits their utilization in diagnosing splenomegaly.

For the detailed list of factors that will drive and challenge the growth of the splenomegaly therapeutics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fairly fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global rare diseases therapeutics market
      • Table Segments of global rare diseases therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline molecules for reduction in spleen size
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Drug therapy - Market size and forecast 2018-2023
      • Table Drug therapy - Market size and forecast 2018-2023 ($ millions)
      • Table JAKAVI/JAKAFI sales in $ millions
      • Table Drug therapy - Year-over-year growth 2019-2023 (%)
    • Vaccination - Market size and forecast 2018-2023
      • Table Vaccination - Market size and forecast 2018-2023 ($ millions)
      • Table Vaccination - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Market segmentation by type
    • Congestive splenomegaly
    • Infiltrative splenomegaly
    • Neoplastic splenomegaly
    • Immune splenomegaly
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • GlaxoSmithKline plc
      • Table GlaxoSmithKline plc - Vendor overview
      • Table GlaxoSmithKline plc - Business segments
      • Table GlaxoSmithKline plc - Organizational developments
      • Table GlaxoSmithKline plc - Geographic focus
      • Table GlaxoSmithKline plc - Segment focus
      • Table GlaxoSmithKline plc - Key offerings
    • Incyte Corporation
      • Table Incyte Corporation - Vendor overview
      • Table Incyte Corporation - Business segments
      • Table Incyte Corporation - Organizational developments
      • Table Incyte Corporation - Key offerings
    • Merck & Co., Inc.
      • Table Merck & Co., Inc. - Vendor overview
      • Table Merck & Co., Inc. - Business segments
      • Table Merck & Co., Inc. - Organizational developments
      • Table Merck & Co., Inc. - Geographic focus
      • Table Merck & Co., Inc. - Segment focus
      • Table Merck & Co., Inc. - Key offerings
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report